big gains on chemgenex adr

outta the blue, some big gains on CXSPY today.

It is actually overpriced in the US right now given the 15:1 ratio to CXS.

I doubt they will find a Euro partner by the end of this quarter. And since the FDA NDA was a couple months late, I expect the EMEA sumbittal to be late as well.

Still a great buy for the next 9-12 months, however.